Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Beats on EPS, Stock Up 0.41%

Collegium Pharmaceutical reported a strong earnings per share, exceeding expectations, which contributed to a slight increase in stock price. However, there was no revenue figure provided, leaving some uncertainty about overall performance. The lack of management commentary and guidance means investors will need to wait for more information to assess future prospects.